Lifevantage (LFVN) Tops Q2 EPS by 8c, offers guidance

Lifevantage (NASDAQ: LFVN) reported Q2 EPS of $0.22, $0.08 better than the analyst estimate of $0.14. Revenue for the quarter came in at $67.8 million versus the consensus estimate of $51.9 million.

GUIDANCE:

Lifevantage sees FY2025 EPS of $0.72-$0.88, versus the consensus of $0.76. Lifevantage sees FY2025 revenue of $235-245 million, versus the consensus of $238.49 million.

For earnings history and earnings-related data on Lifevantage (LFVN) click here.

You May Also Be Interested In

• Ares Management, L.P. (ARES) PT Raised to $153 at TD Cowen
• UBS Reiterates Buy Rating on General Motors (GM) as Defense Opportunity in Focus
• U.S. Bank hires Eric Levine to head healthcare payments unit